Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
VA Office of Research and Development
Guangzhou Red Pine Medical Instrument Co., Ltd.
Travera Inc
Ferring Pharmaceuticals
University of Kansas Medical Center
University of Aberdeen
EMD Serono
Brown University
Second Xiangya Hospital of Central South University
University Health Network, Toronto
University of Kansas Medical Center
QuantumLeap Healthcare Collaborative
National Institutes of Health Clinical Center (CC)
University of British Columbia
University of Southern California
Eastern Cooperative Oncology Group
Pfizer
Rush University Medical Center
Flame Biosciences
Dana-Farber Cancer Institute
Case Comprehensive Cancer Center
University Health Network, Toronto
NKGen Biotech, Inc.
Eisai Inc.
Duke University
Dana-Farber Cancer Institute
University of Wisconsin, Madison
The University of Texas Health Science Center at San Antonio
Stanford University
University of Southern California
Medical Enterprises Europe B.V.
VA Office of Research and Development
Ligartis GmbH
Johns Hopkins University
Washington University School of Medicine
Case Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
UroGen Pharma Ltd.
GE Healthcare
Medical Enterprises Europe B.V.
Bioniche Life Sciences Inc.
Stanford University
University of Colorado, Denver
University of Pittsburgh
Fox Chase Cancer Center
University of Michigan Rogel Cancer Center